Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 3:2:5-11.
doi: 10.1016/j.jctube.2015.11.002. eCollection 2016 Jan.

Peripheral neuropathy in persons with tuberculosis

Affiliations
Review

Peripheral neuropathy in persons with tuberculosis

Arnold T Mafukidze et al. J Clin Tuberc Other Mycobact Dis. .

Abstract

Peripheral neuropathy (PN) is a serious condition affecting the nerves that is commonly seen in patients with tuberculosis (TB). Causes of PN in patients with TB are multiple, and can include TB itself, other co-morbid conditions, such as Human Immune-deficiency virus (HIV) disease, malnutrition, or diabetes mellitus (DM), and several anti-tuberculous medications. The condition can manifest with a variety of symptoms, and a diagnosis can usually be made on a clinical basis. Treatment and prognosis of PN vary depending on the underlying cause, but often the condition can lead to permanent disability in individuals with TB. For this reason, primary prevention is key as is early identification and management of symptoms. Treatment can include withdrawal of possible offending agents, vitamin supplementation, physical therapy, analgesics, and targeted agents, including tricyclic antidepressants, selective serotonin reuptake inhibitors, and gabapentin. Additional research is needed to better describe the morbidity and disability associated with PN in persons with TB and to improve management strategies for persons at risk for and affected by this condition. Case review: RM is a 47 year-old man who is in his third month of treatment for drug-resistant TB (DR-TB). His treatment regimen consists of kanamycin (1 gm intramuscular daily), levofloxacin (1000 mg by mouth daily), cycloserine (750 mg by mouth daily), ethionamide (750 mg by mouth daily), pyrazinamide (1500 mg by mouth daily), and Para-Amino Salicylate (12 gm by mouth daily). He is HIV-infected with a CD4 count of 470 cell/µl and on a stable antiretroviral therapy regimen of tenofovir, lamivudine, and efavirenz, which he started 8 weeks ago. He works in a platinum mine, denies smoking, reports drinking beer "on the weekend" and denies other drugs. He presents for his 3 month clinical visit for his DR-TB follow-up and states he is doing well, but he does report some "burning" in the bottom of his feet.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Subjective Peripheral Neuropathy Scale Instructions: Ask the subject to rate the severity of each symptom listed in Question 1 on a scale of 01 (mild) to 10 (most severe) for right and left feet and legs. Enter the score for each symptom in the columns marked R (right lower limb) and L (left lower limb). If a symptom has been present in the past, but not since the last visit, enter “00 – Currently Absent”. If the symptom has never been present, enter “11 – Always Been Normal”.
Fig 2
Fig. 2
Algorithmic Approach to Peripheral Neuropathy (PN) in Patients with TB All patients with TB should have the following assessments and interventions done to minimize the impact of PN on their health.

References

    1. Torpy J., Kincaid J., Glass M. Peripheral neuropathy. JAMA. 2010;303(15):1556. - PubMed
    1. Smith B., Torrance N. Epidemiology of neuropathic pain and its impact of quality of life. Curr. Pain Headache Rep. 2012 - PubMed
    1. Marks D.J., Dheda K., Dawson R., Ainslie G., Miller R.F. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs. Int J STD AIDS. 2009;20(5):339–345. - PubMed
    1. Azhary H., Farooq M., Bhanushali M. Peripheral neuropathy: differential diagnosis and management. Am Fam Phys. 2010;81(7):887–892. - PubMed
    1. Blain P.G., Lane R.J. Neurological disorders. In: Davies D.M., Ferner R.E., de Glanville H., editors. Davies's Textbook of Adverse Drug Reactions. 5th ed. Chapman and Hall Medical; London, UK: 1998. pp. 585–629.